TELA Bio TELA
NASDAQ TELA
$0.96 +0.02 (+1.66%)
As of: Nov 12, 2026 · 10:16 AM EST

TELA Bio (TELA) Gains (Losses) on Sale of Assets & Investments (2024)

Updated

TELA Bio (TELA) reported Non Operating Investment Income of $7.58 million for FY2024.

Analysis

TELA Bio (TELA) Gains (Losses) on Sale of Assets & Investments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn -
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn -
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn -
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn -
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn -
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 13.00 Mn
10 TELA Bio 46.15 Mn -97.32 Mn 12.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 7.58 Mn
API Access

TELA Bio Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=TELA&period=max&api_key=YOUR_API_KEY